DEKABANK DEUTSCHE GIROZENTRALE – Vertex Pharmaceuticals Incorporated Transaction History
DEKABANK DEUTSCHE GIROZENTRALE portfolio value:
$123.00M
portfolio value
DEKABANK DEUTSCHE GIROZENTRALE quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -10.54% | -49.78K shares | -8.45M | $289.54 | 422.71K |
| Q2 2022 | share | Decrease | -1.59% | -7.63K shares | 7.32M | $281.79 | 472.50K |
| Q1 2022 | share | Increase | +41.95% | 141.88K shares | 48.16M | $260.97 | 480.14K |
| Q4 2021 | share | Decrease | -1.87% | -6.45K shares | 12.99M | $222.45 | 338.25K |
| Q3 2021 | share | Increase | +2.61% | 8.78K shares | -3.14M | $181.39 | 344.70K |
| Q2 2021 | share | Increase | +12.85% | 38.24K shares | 2.53M | $201.63 | 335.92K |
| Q1 2021 | share | Increase | +26.94% | 63.18K shares | 8.90M | $214.89 | 297.67K |
| Q4 2020 | share | Decrease | -8.19% | -20.91K shares | -13.57M | $236.34 | 234.49K |
| Q3 2020 | share | Increase | +310.74% | 193.22K shares | 50.58M | $272.12 | 255.40K |
| Q2 2020 | share | Increase | +6.39% | 3.73K shares | 4.01M | $290.31 | 62.18K |
| Q1 2020 | share | Decrease | -4.72% | -2.89K shares | 150K | $237.95 | 58.44K |
| Q4 2019 | share | Decrease | -73.68% | -171.69K shares | -25.51M | $218.95 | 61.34K |
| Q3 2019 | share | Decrease | -37.72% | -141.13K shares | -27.97M | $169.42 | 233.03K |
| Q2 2019 | share | Increase | +250.81% | 267.50K shares | 46.99M | $183.38 | 374.16K |
| Q1 2019 | share | Increase | +3.37% | 3.47K shares | 3.12M | $183.95 | 106.65K |
| Q4 2018 | share | Decrease | -3.26% | -3.47K shares | -3.12M | $165.71 | 103.18K |
| Q3 2018 | share | Decrease | -22.39% | -30.77K shares | -734K | $192.74 | 106.65K |
| Q2 2018 | share | Decrease | -22.53% | -39.96K shares | -7.79M | $169.96 | 137.43K |
| Q1 2018 | share | Increase | +15.67% | 24.03K shares | 5.19M | $162.98 | 177.39K |
| Q4 2017 | share | 0.00% | 0 shares | 0 | $149.86 | 153.36K | |
| Q3 2017 | share | Decrease | -13.08% | -23.07K shares | 756K | $152.04 | 153.36K |
| Q2 2017 | share | Increase | +3.07% | 5.25K shares | 4.13M | $128.87 | 176.43K |
| Q1 2017 | share | Increase | +0.59% | 1.00K shares | 5.75M | $109.35 | 171.18K |
| Q4 2016 | share | Decrease | -7.30% | -13.39K shares | -2.93M | $73.67 | 170.17K |
| Q3 2016 | share | Decrease | -26.98% | -67.83K shares | -5.75M | $87.21 | 183.57K |
| Q2 2016 | share | Increase | +6.66% | 15.69K shares | 2.89M | $86.02 | 251.40K |
| Q1 2016 | share | Increase | +22.50% | 43.29K shares | -6.07M | $79.49 | 235.70K |